A long term follow up of relapsing remitting multiple sclerosis patien
A long term follow up of relapsing remitting multiple sclerosis patients who have been treated with intereron beta -1b (Betaferon) at least 5 years
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Interferon beta-1b
Interferon alpha/beta receptor agonist
Who could take part
Relapsing MS
Show the full criteria
Inclusion criteria
Inclusion: Group A : RRMS patients (male and female) who have been using Betaferon at least five years and are still using it. Exclusion: Group A: RRMS patients who have been using Betaferon less than five years.
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Group A still continue Betaferon treatment.
Loading reviews and guidelines…
Related trials
- Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting
Phase 3 · Not yet recruiting
Still running
- Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Recruiting
Still running
- Discontinuation of first-line disease modifying treatment (DMT) in lon
Phase 4 · Stopped early
Stopped
- A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY
Running, not recruiting
Still running
- Study to Investigate Pregnancy Outcomes in Female Participants Exposed
Completed
Paper found, not read
- A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017
Phase 3 · Running, not recruiting
Still running
History
Started
Dec 2005